Cargando…
MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
Colorectal cancer (CRC) is one of the most common and deadliest forms of cancer. Myeloid Cell Leukemia 1 (MCL1), a pro-survival member of the Bcl-2 protein family is associated with chemo-resistance in CRC. The ability of MCL1 to inhibit apoptosis by binding to the BH3 domains of pro-apoptotic Bcl-2...
Autores principales: | Fu, Dechen, Pfannenstiel, Luke, Demelash, Abeba, Phoon, Yee Peng, Mayell, Cameron, Cabrera, Claudia, Liu, Caini, Zhao, Junjie, Dermawan, Josephine, Patil, Deepa, DeVecchio, Jennifer, Kalady, Matthew, Souers, Andrew J., Phillips, Darren C., Li, Xiaoxia, Gastman, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766550/ https://www.ncbi.nlm.nih.gov/pubmed/35042842 http://dx.doi.org/10.1038/s41419-021-04334-y |
Ejemplares similares
-
Raiding the pharmacy: genomic screening identifies known chemotherapies as negative
regulators of MCL1
por: Pfannenstiel, Lukas W, et al.
Publicado: (2012) -
Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence
por: Demelash, Abeba, et al.
Publicado: (2017) -
Mcl-1 and tumor cell persistence
por: Pfannenstiel, Lukas W., et al.
Publicado: (2014) -
Mcl-1 expression influcences CD8+ anti-tumor immunity.
por: Pfannenstiel, Lukas W, et al.
Publicado: (2015) -
Tumor-induced suppressive CD8+ T cells: implications for cancer immunotherapy
por: Pfannenstiel, Lukas W, et al.
Publicado: (2013)